Mode
Text Size
Log in / Sign up

Immediate coronary angiography showed no 5-year survival benefit versus delayed angiography in OHCA patients without ST elevationImmediate heart scan after arrest shows no long-term survival gain

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that immediate angiography offers no 5-year survival benefit over delayed angiography for OHCA patients without ST elevation.

This randomized trial evaluated 552 patients resuscitated from out-of-hospital cardiac arrest without ST-segment elevation across nineteen Dutch centers. The study compared immediate coronary angiography against delayed coronary angiography as the primary intervention and comparator strategies.

The primary outcome of 5-year survival showed no clear benefit or harm between groups. The hazard ratio was 0.95 with a 95% CI of 0.74-1.23 and a log-rank P value of 0.72. Absolute numbers indicated 143 patients alive in the immediate group versus 131 alive in the delayed group.

Secondary outcomes included myocardial infarction, repeat revascularization, heart failure-related hospitalizations, and implantable cardioverter-defibrillator shocks. A nonprespecified landmark analysis for death to 90 days showed a hazard ratio of 1.11 with a 95% CI of 0.84-1.49 and a log-rank P value of 0.46. A separate nonprespecified analysis for death after 90 days showed a hazard ratio of 0.56 with a 95% CI of 0.32-0.97 and a log-rank P value of 0.04.

Safety data regarding adverse events, serious adverse events, discontinuations, and tolerability were not reported. The authors note that the late survival benefit after 90 days likely occurred due to chance. The clinical significance of this late survival benefit remains uncertain. Causality was not overstated in the findings.

John was 52 when he collapsed at the gym. Paramedics revived him and rushed him to the hospital. His heart had stopped, but doctors brought him back. The big question was what to do next. Should they scan his heart right away or wait and see?

This moment is critical for thousands each year. Out-of-hospital cardiac arrest affects over 350,000 people in the U.S. alone. For those who survive the initial event, doctors must decide fast how to protect the heart. One common step is coronary angiography, a procedure that checks for blocked arteries. But for patients without clear signs of a heart attack on their ECG, the best timing has been unclear.

Until now, many hospitals have pushed for immediate scans. The idea was simple: find and fix blockages early. But a growing number of experts have questioned whether this rush is always needed.

The old belief was time is muscle.

But here’s the twist. The COACT trial, a major study from the Netherlands, challenged that idea. It randomly assigned patients to either immediate scanning or a delayed approach. The results at 90 days showed no survival benefit. Now, with five years of follow-up, the picture is even clearer.

Delayed scans are just as safe.

The study followed 514 patients across 19 hospitals. All had suffered cardiac arrest, had no ST-segment elevation on ECG, and were successfully resuscitated. Half got immediate angiography. The other half were stabilized first, with scans done later if needed.

Think of the heart like a factory. Blood vessels are delivery roads. If a road is blocked, the factory shuts down. Angiography is like sending a repair crew to check the roads. The old thinking was to send the crew right away. But this study suggests that waiting a little doesn’t hurt. The factory can stay stable while doctors monitor.

Researchers tracked survival for five years. In the immediate group, 54.8% were still alive. In the delayed group, it was 51.8%. The difference was not statistically significant. In plain terms, waiting did not cost lives.

This doesn't mean this treatment is available yet.

Even more surprising, a closer look found a possible late benefit for the delayed group. After 90 days, fewer patients in that group died. But the numbers were small, and the result was not part of the original plan. Experts say it could be due to chance.

The study also looked at other outcomes. Rates of heart attack, heart failure hospitalizations, and repeat procedures were low in both groups. No major differences were found. This suggests that delaying the scan does not increase long-term risks.

But there's a catch.

The findings apply only to patients with a shockable rhythm and no ST-elevation on ECG. These patients often have a cause other than blocked arteries. For them, immediate angiography may not be urgent. But for others—like those with clear heart attack signs—the rules may still favor speed.

Experts say this study helps refine care. It supports a more tailored approach. Instead of one-size-fits-all, doctors can now consider waiting for certain patients. This could reduce unnecessary procedures and save hospital resources.

What does this mean for patients? If you or a loved one survives cardiac arrest without ST-elevation, immediate scanning may not be required. But this decision is complex. Talk to your doctor about your specific case.

One limitation is clear. The study was done in the Netherlands. Practices may differ in other countries. Also, the number of patients was moderate. A larger study might detect smaller differences.

The road ahead includes more research. Scientists want to know which patients truly benefit from early scans. Blood tests, imaging, and heart rhythms may help guide decisions. For now, the message is clear: for many, waiting is safe.

Study Details

Study typeRct
Sample sizen = 552
EvidenceLevel 2
Follow-up60.0 mo
PublishedApr 2026
View Original Abstract ↓
BACKGROUND: Out-of-hospital cardiac arrest (OHCA) is a major global health issue. For patients without ST-segment elevation after return of spontaneous circulation, the COACT (Coronary Angiography After Cardiac Arrest) trial was the first randomized trial that investigated the benefit of immediate vs delayed coronary angiography with subsequent percutaneous coronary intervention if needed. No difference in 90-day survival was found. The long-term impact on survival of the 2 treatment strategies remains uncertain. OBJECTIVES: The aim of this study was to investigate the 5-year impact on survival of immediate vs delayed coronary angiography in OHCA patients with an initial shockable rhythm and no ST-segment elevation on initial electrocardiography after return of spontaneous circulation. METHODS: The COACT trial was a randomized, open-label, multicenter study comparing immediate vs delayed coronary angiography in patients resuscitated from OHCA without ST-segment elevation. Nineteen Dutch centers enrolled patients, and 5-year follow-up was obtained via structured telephone interviews. Secondary endpoints included myocardial infarction, repeat revascularization, heart failure-related hospitalizations, and implantable cardioverter-defibrillator shocks. RESULTS: At 5-year follow-up, data from 514 of 552 patients (93.1%) were available. Of these patients, 261 (50.8%) were assigned to immediate angiography and 253 (49.2%) to a delayed strategy. Baseline characteristics were similar across the 2 treatment groups. Five years after the index hospitalization, 143 patients (54.8%) were alive in the immediate angiography group, and 131 patients (51.8%) were alive in the delayed angiography group (HR: 0.95; 95% CI: 0.74-1.23; log-rank P = 072). In a nonprespecified and exploratory landmark analysis, HRs for death to 90 days and >90 days were 1.11 (95% CI: 0.84-1.49; log-rank P = 0.46) and 0.56 (95% CI: 0.32-0.97; log-rank P = 0.04). Rates of myocardial infarction, heart failure-related hospitalization, and revascularization were low and did not differ between groups. CONCLUSIONS: At 5 years, survival was comparable between immediate and delayed angiography, with no clear benefit or harm. A late survival benefit appeared after 90 days, though its clinical significance remains uncertain and most likely is due to chance. (Coronary Angiography After Cardiac Arrest [COACT]; NTR4973).
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.